These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21528740)

  • 1. Who shall live when not all can live? Intellectual property in accessing and benefit-sharing influenza viruses through the World Health Organisation.
    Lawson C
    J Law Med; 2011 Mar; 18(3):554-76. PubMed ID: 21528740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levelling the playing field? Sharing of influenza viruses and access to vaccines and other benefits.
    Jefferies N
    J Law Med; 2012 Sep; 20(1):59-72. PubMed ID: 23156648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing the effect of TRIPS on availability of priority vaccines.
    Milstien J; Kaddar M
    Bull World Health Organ; 2006 May; 84(5):360-5. PubMed ID: 16710544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
    Cohen-Kohler JC; Forman L; Lipkus N
    Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the World Trade Organization TRIPS agreement on the pharmaceutical industry in Thailand.
    Supakankunti S; Janjaroen WS; Tangphao O; Ratanawijitrasin S; Kraipornsak P; Pradithavanij P
    Bull World Health Organ; 2001; 79(5):461-70. PubMed ID: 11417042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trade-Related Aspects of Intellectual Property Rights Flexibilities and Public Health: Implementation of Compulsory Licensing Provisions into National Patent Legislation.
    McGIVERN L
    Milbank Q; 2023 Dec; 101(4):1280-1303. PubMed ID: 37646392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries.
    Andanda PA
    J Med Ethics; 2008 Mar; 34(3):171-9. PubMed ID: 18316458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trade, TRIPS, and pharmaceuticals.
    Smith RD; Correa C; Oh C
    Lancet; 2009 Feb; 373(9664):684-91. PubMed ID: 19167054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious diseases. 'Breakthrough' deal on flu strains has modest provisions.
    Enserink M
    Science; 2011 Apr; 332(6029):525. PubMed ID: 21527688
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intellectual property rights and right of access to medicines].
    Velásquez G
    Med Trop (Mars); 2006 Dec; 66(6):526-8. PubMed ID: 17286013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The right to health and medicines: the case of recent multilateral negotiations on public health, innovation and intellectual property.
    Velasquez G
    Dev World Bioeth; 2014 Aug; 14(2):67-74. PubMed ID: 24813066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The World Trade Organization: implications for health policy.
    Koivusalo M; Rowson M
    Med Confl Surviv; 2000; 16(2):175-91. PubMed ID: 10893939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of bilateral free trade agreements on access to medicines.
    Correa CM
    Bull World Health Organ; 2006 May; 84(5):399-404. PubMed ID: 16710551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WTO ministerial conference adopts declaration on TRIPS and public health.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2002 Mar; 6(3):50-2. PubMed ID: 14979260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of intellectual property rights in treatment access: challenges and solutions.
    't Hoen E; Passarelli CA
    Curr Opin HIV AIDS; 2013 Jan; 8(1):70-4. PubMed ID: 23201855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATT and the gap: how to save lives.
    James JS
    AIDS Treat News; 1998 Nov; (No 307):1, 3-6. PubMed ID: 11366123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries.
    Orsi F; d'almeida C
    Curr Opin HIV AIDS; 2010 May; 5(3):237-41. PubMed ID: 20539080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges for intellectual property management of HIV vaccine-related research and development: part 1, the global context.
    Knowles L; Bubela T
    Health Law J; 2008; 16():55-95. PubMed ID: 19536978
    [No Abstract]   [Full Text] [Related]  

  • 20. Trade agreements, intellectual property, and the role of the World Bank in improving access to medicines in developing countries.
    Rovira J
    Yale J Health Policy Law Ethics; 2004; 4(2):401-13. PubMed ID: 15536921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.